Physician profile
Jorge D Sanchez
NPI 1295701506
$3,185.62
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $1,039 · 2021: $1,167 · 2022: $431.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $437.67 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $355.87 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $339.26 | 2019-2022 | |
| Greenwich Biosciences, INC. | $331.86 | 2019-2021 | |
| Ucb, INC. | $210.95 | 2019-2022 | |
| Lundbeck LLC | $139.60 | 2020-2021 | |
| Amgen INC. | $118.10 | 2019-2021 | |
| Abbvie INC. | $117.92 | 2021-2022 | |
| Allergan, INC. | $117.68 | 2020-2022 | |
| Genzyme Corporation | $92.51 | 2019-2020 | |
| Livanova USA, INC. | $84.35 | 2019-2021 | |
| Kyowa Kirin, INC. | $75.54 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $72.94 | 2020-2022 | |
| Biogen, INC. | $63.63 | 2019-2021 | |
| Harmony Biosciences LLC | $63.14 | 2020-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $56.97 | 2020-2021 | |
| Travere Therapeutics, INC. | $53.42 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $53.21 | 2019-2021 | |
| Csl Behring | $48.57 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $48.57 | 2020-2021 | |
| Aquestive Therapeutics, INC. | $38.64 | 2020 | |
| Celgene Corporation | $35.03 | 2020 | |
| Supernus Pharmaceuticals, INC. | $28.59 | 2019 | |
| Zogenix INC. | $28.21 | 2021 | |
| Emd Serono, INC. | $27.44 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $19.87 | 2021 | |
| Ge Healthcare | $19.44 | 2020 | |
| Jazz Pharmaceuticals INC. | $16.18 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $15.63 | 2021 | |
| Avanir Pharmaceuticals, INC. | $13.56 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $13.30 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.38 | 2022 | |
| Grifols USA, LLC | $12.10 | 2021 | |
| Sk Life Science, INC. | $11.84 | 2020 | |
| Genentech USA, INC. | $11.65 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.